Parkinson's disease (PD) is a neurodegenerative disorder that primarily affects dopamine-producing neurons in the substantia nigra. This article aims to provide a comprehensive understanding of the disease, its diagnosis, and management strategies.
The pathogenesis of PD is multifactorial, involving both genetic and environmental factors. The hallmark pathological feature is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency. This results in the classic motor symptoms of PD: bradykinesia, rigidity, and rest tremor.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and the absence of atypical features or secondary causes. The Movement Disorder Society (MDS) clinical diagnostic criteria for PD is a widely accepted tool. Neuroimaging, although not routinely used, can aid in uncertain cases.
The management of PD is multidimensional, involving pharmacologic and non-pharmacologic interventions. Levodopa remains the most effective treatment for motor symptoms. Dopamine agonists, MAO-B inhibitors, and deep brain stimulation are other treatment options. Non-pharmacologic interventions include physical therapy and occupational therapy. Patient education and support are crucial components of care.
Understanding the pathophysiology, diagnosis, and management of Parkinson's disease is fundamental for healthcare professionals. While there is currently no cure, early diagnosis and comprehensive management can significantly improve the quality of life of patients. Continued research and advancements in therapy offer hope for future breakthroughs in the fight against this debilitating disease.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation